3 authorised products containing Recombinant human igg1 monoclonal antibody to fibroblast growth factor 23, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| CRYSVITA 10 mg solution for injection EU/1/17/1262/001 |
Recombinant human igg1 monoclonal antibody to fibroblast growth factor 23 | Kyowa Kirin Holdings B.V. | โ |
| CRYSVITA 20 mg solution for injection EU/1/17/1262/002 |
Recombinant human igg1 monoclonal antibody to fibroblast growth factor 23 | Kyowa Kirin Holdings B.V. | โ |
| CRYSVITA 30 mg solution for injection EU/1/17/1262/003 |
Recombinant human igg1 monoclonal antibody to fibroblast growth factor 23 | Kyowa Kirin Holdings B.V. | โ |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 15 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (โAuthorised or Transfer Pending Productsโ), licensed CC BY 4.0, refreshed daily. Regulatory information only โ not medical advice.